Total Payments
$2,068
2024 Payments
$957.84
Companies
28
Transactions
134
Payment Breakdown by Category
Food & Beverage$2,056 (99.4%)
Education$11.56 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,056 | 133 | 99.4% |
| Education | $11.56 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $557.91 | 47 | $0 (2024) |
| Novo Nordisk Inc | $244.81 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $232.66 | 8 | $0 (2024) |
| Lilly USA, LLC | $163.04 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $131.21 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $91.12 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.30 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $53.48 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.48 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $41.13 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.84 | 54 | ABBVIE INC. ($222.05) |
| 2023 | $531.58 | 38 | ABBVIE INC. ($182.48) |
| 2022 | $578.62 | 42 | ABBVIE INC. ($153.38) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Obesity | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Biological | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Biological | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Obesity | ||||||
| 08/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Inflammation | ||||||
| 07/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Biological | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PAIN | ||||||
About Erica Baumgartner
Erica Baumgartner is a Emergency healthcare provider based in New Castle, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1801260898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erica Baumgartner has received a total of $2,068 in payments from pharmaceutical and medical device companies, with $957.84 received in 2024. These payments were reported across 134 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,056).
Ad
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location New Castle, IN
- Active Since 11/14/2015
- Last Updated 09/09/2020
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1801260898
Products in Payments
- VRAYLAR (Drug) $275.55
- AIRSUPRA (Drug) $146.04
- Kerendia (Drug) $131.21
- QULIPTA (Drug) $117.54
- MOUNJARO (Drug) $114.41
- UBRELVY (Drug) $96.97
- JARDIANCE (Drug) $79.09
- Wegovy (Drug) $78.81
- NURTEC ODT (Drug) $68.43
- Rybelsus (Drug) $67.90
- Ozempic (Drug) $65.96
- CAPLYTA (Drug) $56.45
- Veozah (Drug) $53.48
- GLASSIA (Biological) $45.48
- FARXIGA (Drug) $45.27
- BEXSERO (Biological) $44.29
- REXULTI (Drug) $41.13
- TYVASO (Drug) $41.05
- CREON (Drug) $40.36
- Auvelity (Drug) $29.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.